Washington Post
To strengthen their position with the new Democrat-controlled Congress, drug companies and their trade groups have been hiring top Democratic lobbyists to gain access to new committee chairmen, bolstering Democratic political donations and spending millions on public relations campaigns to overcome an image that the industry puts profits ahead of patients. This month alone, the Pharmaceutical Research and Manufacturers of America spent more than $1 million on full-page newspaper ads touting the success of the existing Medicare drug system. ... FULL STORY
